<DOC>
	<DOCNO>NCT03045055</DOCNO>
	<brief_summary>Ischemic stroke , due occlusion cerebral blood vessel , comprise nearly 90 % stroke . Currently , reperfusion salvageable tissue via thrombolytic drug endovascular treatment effective strategy reduce brain damage . However , recanalizing occlude vessel , subsequent reperfusion injury inevitable . It may weaken therapeutic effect timely reperfusion also impede patient ' recovery . Moreover , thousand neuroprotective drug effective experimental model prove unsuccessful clinical trial . Therefore , effective strategy urgently need prevent treat cerebral reperfusion injury improve prognosis acute ischemic stroke . Researchers apply remote ischemic conditioning mouse model focal cerebral reperfusion injury find could reduce cerebral infarct size . And clinical research demonstrate remote ischemic conditioning effective strategy improve cerebral perfusion prevent recurrent stroke patient ischemic stroke . However , whether remote ischemic conditioning safe effective protect patient large-vessel ischemic stroke undergo endovascular treatment still unknown . The investigator ' hypothesis RIC safe , feasible effective strategy reduce cerebral reperfusion injury endovascular treatment .</brief_summary>
	<brief_title>Remote Ischemic Conditioning Paired With Endovascular Treatment Acute Ischemic Stroke</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<criteria>1 . Acute ischemic stroke patient ineligible intravenous thrombolytic treatment treatment contraindicate , patient receive intravenous thrombolytic therapy without recanalization ; 2 . The ASITN/SIR collateral grade scale &lt; 2 recanalizing TICI &gt; 1 recanalizing , score determine DSA imaging ; 3 . No remarkable prestroke functional disability ( mRS ≤ 1 ) ; 4 . Baseline NIHSS score obtain prior randomization must ≥6 ; 5 . Age ≥18 ≤ 80 ; 6 . Occlusion ( TICI 01 ) intracranial middle cerebral artery M1 segment , evidence angiogram ; 7 . Patient treatable within six hour symptom onset ; 8 . Informed consent obtain patient acceptable patient 's surrogate Clinical criterion 1 . Identified hemorrhagic diathesis , coagulation factor deficiency , oral anticoagulant therapy INR &gt; 3.0 ; 2 . Baseline platelet count &lt; 30*109/L ; 3 . Baseline blood glucose &lt; 2.7mmol/L &gt; 22.2mmol/L ; 4 . Renal insufficiency creatinine ≥ 265 umol/L ; 5 . Severe , sustain hypertension ( SBP &gt; 185 mmHg DBP &gt; 110 mmHg ) ; 6 . Rapidly improve symptom discretion investigator ; 7 . Seizures stroke onset would preclude obtain baseline NIHSS ; 8 . Serious , advanced , terminal illness anticipate life expectancy le one year ; 9 . History life threaten allergy contrast medium , Nickel , Titanium metal alloy ; 10 . Woman childbearing potential know pregnant lactate positive pregnancy test admission ; 11 . Subject participate study involve drug device trial study ; 12 . Patients preexist neurological psychiatric disease would confound neurological functional evaluation ; 13 . Unlikely available 90day followup ; 14 . Contraindication remote ischemic conditioning : severe soft tissue injury , fracture , peripheral vascular disease upper limb ; Neuroimaging criterion : 15 . Hypodensity CT restrict diffusion amount ASPECTS score &lt; 7 noncontrast CT &lt; 6 DWI MRI ; 16 . CT MRI evidence hemorrhage ; 17 . Significant mass effect midline shift CT MRI scan ; 18 . Angiogram show arterial tortuosity , preexist stent , and/or arterial disease , would prevent device reach target vessel and/or preclude safe recovery device ; 19 . Subjects artery occlusion multiple vascular territory ; 20 . Evidence intracranial tumor .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Acute ischemic stroke</keyword>
	<keyword>Endovascular treatment</keyword>
	<keyword>Remote ischemic conditioning</keyword>
</DOC>